Skip to main content
. 2020 Apr 22;2020:1451864. doi: 10.1155/2020/1451864

Table 1.

Demographic and clinical data of 674 ESCC patients according to LMR change.

Characteristics N = 674 (%) LMRc P value
≤1.59 (N = 337) (%) >1.59 (N = 337) (%)
Sex
 Male 576 (85.5) 307 (91.1) 269 (79.8) <0.001
 Female 98 (14.5) 30 (8.9) 68 (20.2)
Age
 ≤60 years 310 (46.0) 146 (43.3) 164 (48.7) 0.164
 >60 years 364 (54.0) 191 (56.7) 173 (51.3)
Pathology grade
 Well 49 (7.4) 23 (7.0) 26 (7.8) 0.304
 Middle 446 (67.5) 231 (70.0) 215 (65.0)
 Poorly 164 (24.8) 76 (23.0) 88 (26.6)
 Undifferentiated 2 (0.3) 0 (0) 2 (0.6)
Depth of tumor
 T1a–1b 64 (9.5) 29 (8.6) 35 (10.4) 0.670
 T2 129 (19.1) 63 (18.7) 66 (19.6)
 T3 481 (71.4) 245 (72.7) 236 (70.0)
Lymph node metastasis
 N0 293 (43.5) 150 (44.5) 143 (42.4) 0.142
 N1 212 (31.5) 101 (30.0) 111 (32.9)
 N2 117 (17.4) 53 (15.7) 64 (19.0)
 N3 52 (7.7) 33 (9.8) 19 (5.6)
Pathological stage
 1a–1b 115 (17.1) 56 (16.6) 59 (17.5) 0.949
 2a–2b 226 (33.5) 113 (33.5) 113 (33.5)
 3a–3c 333 (49.4) 168 (49.9) 165 (49.0)
Vessel invasive
 Yes 206 (30.6) 101 (30.0) 105 (31.2) 0.738
 No 468 (69.4) 236 (70.0) 232 (68.8)
Nerve infiltration
 Yes 251 (37.2) 125 (37.1) 126 (37.4) 0.936
 No 423 (62.8) 212 (62.9) 211 (62.6)
Treatment regimen
 S 457 (67.8) 224 (66.5) 233 (69.1) 0.757
 S+postoperative C 155 (23.0) 81 (24.0) 74 (22.0)
 S+postoperative CRT 62 (9.2) 32 (9.5) 30 (8.9)
Hospital time
 ≤14 days 560 (83.1) 265 (78.6) 295 (87.5) 0.002
 >14 days 114 (16.9) 72 (21.4) 42 (12.5)
NLRc
 Median -3.02 (-4.64–-1.69) -2.26 (-3.93–-0.95) -3.78 (-5.39–-2.49) <0.001
LMRc
 Median 1.59 (0.71-2.69) 0.71 (0.05-1.19) 2.68 (2.02-3.54) <0.001
PLRc
 Median -104.89 (-162.16–-54.85) -100.65 (-159.19–-38.38) -108.64 (-163.21–-72.47) 0.003